Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269541
Max Phase: Preclinical
Molecular Formula: C29H23NO4
Molecular Weight: 449.51
Associated Items:
ID: ALA5269541
Max Phase: Preclinical
Molecular Formula: C29H23NO4
Molecular Weight: 449.51
Associated Items:
Canonical SMILES: O=C1/C(=C/c2ccccc2)CN(C(=O)/C=C/c2ccc3c(c2)OCO3)C/C1=C\c1ccccc1
Standard InChI: InChI=1S/C29H23NO4/c31-28(14-12-23-11-13-26-27(17-23)34-20-33-26)30-18-24(15-21-7-3-1-4-8-21)29(32)25(19-30)16-22-9-5-2-6-10-22/h1-17H,18-20H2/b14-12+,24-15+,25-16+
Standard InChI Key: ILFANWLKOIDGAP-QGUFRGFCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 449.51 | Molecular Weight (Monoisotopic): 449.1627 | AlogP: 5.01 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.49 | CX LogD: 5.49 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.53 | Np Likeness Score: -0.06 |
1. Moreira J, Saraiva L, Pinto MM, Cidade H.. (2020) Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies., 192 [PMID:32172081] [10.1016/j.ejmech.2020.112177] |
Source(1):